References

A surveillance study of adenovirus infection in adult solid organ transplant recipients

10.1111/j.1600-6143.2005.01033.x · 2005 · External reference

Adenovirus disease after kidney transplantation: course of infection and outcome in relation to blood viral load and immune recovery

10.1111/j.1600-6143.2011.03479.x · 2011 · External reference

Cell-free DNA and active rejection in kidney allografts

10.1681/asn.2016091034 · 2017 · External reference

Donor-derived cell-free DNA and the prediction of BK virus-associated nephropathy

2020 · External reference

Adenovirus interstitial nephritis and rejection in an allograft

10.1681/asn.2010090941 · 2011 · External reference

Disseminated adenovirus nephritis after kidney transplantation

10.1016/j.ekir.2017.08.004 · 2017 · External reference

The pathologic spectrum of adenovirus nephritis in the kidney allograft

10.1016/j.kint.2022.10.025 · 2023 · External reference

AJKD atlas of renal pathology: adenovirus infection

10.1053/j.ajkd.2017.11.001 · 2018 · External reference

Single-cell analysis reveals host S phase drives large T antigen expression during BK polyomavirus infection

2024 · External reference

The Adenovirus Death Protein - a small membrane protein controls cell lysis and disease

10.1002/1873-3468.13848 · 2020 · External reference

Treatment of adenovirus disease in stem cell transplant recipients with cidofovir

10.1016/j.bbmt.2006.08.040 · 2007 · External reference

Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection

10.1086/380450 · 2004 · External reference

10.1038/sj.bmt.1703798

10.1038/sj.bmt.1703798 · 2003 · External reference

Brincidofovir is not a substrate for the human organic anion transporter 1: a mechanistic explanation for the lack of nephrotoxicity observed in clinical studies

10.1097/ftd.0000000000000353 · 2016 · External reference

Brincidofovir for asymptomatic adenovirus viremia in pediatric and adult allogeneic hematopoietic cell transplant recipients: a randomized placebo-controlled phase II trial

10.1016/j.bbmt.2016.12.621 · 2017 · External reference

Hypogammaglobulinemia and infection risk in solid organ transplant recipients

10.1097/mot.0b013e3283186bbc · 2008 · External reference

Adjunctive use of cidofovir and intravenous immunoglobulin to treat invasive adenoviral disease in solid organ transplant recipients

10.1002/phar.2194 · 2018 · External reference

Life-threatening adenovirus infection in a kidney transplant recipient

2009 · External reference